Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function

Human Reproduction

Volumn 26, Issue 8, 2011, Pages 2077-2083

  Karimov, C B ^a   Moragianni, V A ^b,c   Cronister, A ^d   Srouji, S ^e   Petrozza, J ^a   Racowsky, C ^e   Ginsburg, E ^e   Thornton, K L ^b   Welt, C K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BOSTON IVF   (United States)

^d Esoterix Genetic Laboratories LLC   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

fragile X syndrome; infertility; intermediate repeat; ovarian aging; primary ovarian insufficiency

Indexed keywords

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FMRI GENE; FRAGILE X ASSOCIATED PRIMARY OVARIAN INSUFFICIENCY; FRAGILE X SYNDROME; GENE; GENETIC SCREENING; HUMAN; MUTATIONAL ANALYSIS; PRACTICE GUIDELINE; PREMATURE OVARIAN FAILURE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 79960533734     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der168     Document Type: Article

References (36)

1. ACOG. ACOGCommittee Opinion No. 469: carrier screening for fragile X syndrome. Obstet Gynecol 2010;116:1008-1010.
2. Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, Charen K, He W, Taylor K, Sherman SL. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod 2007;22:2142-2152. (Pubitemid 47241859)
3. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in fragile X study-preliminary data. Am J Med Genet 1999;83:322-325. (Pubitemid 29162637)
4. Bennett CE, Conway GS, Macpherson JN, Jacobs PA, Murray A. Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure. Hum Reprod 2010;25:1335-1338.
5. Bodega B, Bione S, Dalpra L, Toniolo D, Ornaghi F, Vegetti W, Ginelli E, Marozzi A. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 2006;21:952-957.
6. Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005;117:376-382. (Pubitemid 41194564)
7. Bugge M, Bruun-Petersen G, Brondum-Nielsen K, Friedrich U, Hansen J, Jensen G, Jensen PK, Kristoffersson U, Lundsteen C, Niebuhr E et al. Disease associated balanced chromosome rearrangements: a resource for large scale genotype-phenotype delineation in man. J Med Genet 2000;37:858-865.
8. Bussani C, Papi L, Sestini R, Baldinotti F, Bucciantini S, Bruni V, Scarselli G. Premature ovarian failure and fragile X premutation: a study on 45 women. Eur J Obstet Gynecol Reprod Biol 2004;112:189-191. (Pubitemid 38117338)
9. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 1998;13:1184-1187. (Pubitemid 28279167)
10. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-606. (Pubitemid 16116286)
11. Ennis S, Ward D, Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet 2006;14:253-255. (Pubitemid 43135871)
12. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG Jr, Warren ST et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-1058. (Pubitemid 121001519)
13. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Mullerian hormone. Fertil Steril 2009a;91:1700-1706.
14. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil Steril 2009b;91:1707-1711.
15. Hundscheid RD, Braat DD, Kiemeney LA, Smits AP, Thomas CM. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum Reprod 2001;16:457-462. (Pubitemid 32218793)
16. Hunter JE, Epstein MP, Tinker ST, Charen K, Sherman SL. Fragile X-associated primary ovarian insufficiency (FXPOI): evidence foradditional genetic contributions to severity. Gen Epidemiology 2008; 32:553-559.
17. Klipstein S, Regan M, Ryley DA, Goldman MB, Alper MM, Reindollar RH. One last chance for pregnancy: a review of 2705 in vitro fertilization cycles initiated in women age 40 years and above. Fertil Steril 2005; 84:435-445. (Pubitemid 41125267)
18. Laml T, Preyer O, UmekW, Hengstschlager M, Hanzal H. Genetic disorders in premature ovarian failure. Hum Reprod Update 2002;8:483-491. (Pubitemid 35175208)
19. Mallolas J, Duran M, Sanchez A, Jimenez D, Castellvi-Bel S, Rife M, Mila M. Implications of the FMR1 gene in menopause: study of 147 Spanish women. Menopause 2001;8:106-110. (Pubitemid 32199675)
20. Marozzi A, Manfredini E, Tibiletti MG, Furlan D, Villa N, Vegetti W, Crosignani PG, Ginelli E, Meneveri R, Dalpra L. Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum Genet 2000;107:304-311.
21. McConkie-Rosell A, Abrams L, Finucane B, Cronister A, Gane LW, Coffey SM, Sherman S, Nelson LM, Berry-Kravis E, Hessl D et al. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. J Genet Couns 2007;16:593-606. (Pubitemid 350163646)
22. Murray A. Premature ovarian failure and the FMR1 gene. Semin Reprod Med 2000;18:59-66. (Pubitemid 32182822)
23. Murray A,Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 1998; 35:637-640. (Pubitemid 28371973)
24. Murray A, Ennis S, MacSwiney F, Webb J, Morton NE. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet 2000;8:247-252. (Pubitemid 30336176)
25. Nahum R, Shifren JL, Chang Y, Leykin L, Isaacson K, Toth TL. Antral follicle assessment as a tool for predicting outcome in IVF-is it a better predictor than age and FSH? J Assist Reprod Genet 2001; 18:151-155. (Pubitemid 32520027)
26. Nolin SL, Brown WT, Glicksman A, Houck GE, Gargano AD, Sullivan A, Biancalana V, Brondum-Nielsen K, Hjalgrim H, Holinski-Feder E et al. Expansion of the fragile X CGG repeat in females with permutation or intermediate alleles. Am J Hum Genet 2003;72:454-464. (Pubitemid 36194253)
27. Rajendra K, Bringman JJ, Ward J, Phillips OP. Who should be tested for fragile X carriership? A review of 1 center's pedigrees. Am J Obstet Gynecol 2008;198:e51-e53.
28. Rohr J, Allen EG, Charen K, Giles J, He W, Dominguez C, Sherman SL. Anti-Mullerian Hormone (AMH) indicates early ovarian decline in FMR1 premutation carriers: a preliminary study. Hum Reprod 2008; 23:1220-1225. (Pubitemid 351757318)
29. Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 2000;97:189-194. (Pubitemid 32059206)
30. Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med 2005;7:584-587. (Pubitemid 41566485)
31. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 1993;53:1217-1228. (Pubitemid 23346220)
32. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 2005;20:402-412. (Pubitemid 40277608)
33. Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Med Genet 1996;64:196-197.
34. Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 2007;68:499-509. (Pubitemid 351388699)
35. Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 2004;89:4569-4574. (Pubitemid 39244471)
36. Yanushpolsky EH, Hurwitz S, Tikh E, Racowsky C. Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in women younger than 40 years of age. Fertil Steril 2003;80:111-115. (Pubitemid 36808865)